Patents by Inventor Mohammad Mehdi Amiri

Mohammad Mehdi Amiri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Production of hersintuzumab: a new humanized antibody against HER2 for cancer treatment
    Patent number: 10167342
    Abstract: A monoclonal anti-HER2 antibody is mutated on complementarity determining regions (CDRs) and framework regions. The VH domain of the antibody includes a portion of the amino acid sequence as SEQ ID NO: 1. The VL domain of the antibody includes a portion of the amino acid sequence as SEQ ID NO: 5.
    Type: Grant
    Filed: August 29, 2016
    Date of Patent: January 1, 2019
    Inventors: Fazel Shokri, Mahmood Jeddi-Tehrani, Mohammad Mehdi Amiri
  • PRODUCTION OF HERSINTUZUMAB: A NEW HUMANIZED ANTIBODY AGAINST HER2 FOR CANCER TREATMENT
    Publication number: 20170066829
    Abstract: A monoclonal anti-HER2 antibody is mutated on complementarity determining regions (CDRs) and framework regions. The VH domain of the antibody includes a portion of the amino acid sequence as SEQ ID NO: 1. The VL domain of the antibody includes a portion of the amino acid sequence as SEQ ID NO: 5.
    Type: Application
    Filed: August 29, 2016
    Publication date: March 9, 2017
    Inventors: Fazel Shokri, Mahmood Jeddi-Tehrani, Mohammad Mehdi Amiri